http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-101760246-B1
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-136 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-156 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6876 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-68 |
| filingDate | 2015-04-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2017-07-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2017-07-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-101760246-B1 |
| titleOfInvention | Novel SLCO2B1 Single Nucleotide Polymorphism Markers and Uses Thereof |
| abstract | The present invention relates to a novel single nucleotide polymorphism (SNP) present in the gene of SLCO2B1 (Solute carrier organic anion transporter family member 2B1) and its use as a marker for predicting drug response, and more particularly to a SLCO2B1 single nucleotide polymorphism A drug reaction prediction or diagnosis kit, a method of providing information for drug selection determination, a method for detecting a mutation genotype of a gene associated with a drug reaction, and a method for providing information on a single nucleotide polymorphism of the SLCO2B1 gene will be. The novel SLCO2B1 single nucleotide polymorphism markers presented in the present invention can be useful as biomarkers related to drug transporter dysfunction. That is, the novel SLCO2B1 single nucleotide polymorphism of the present invention can be used as a biomarker to predict or diagnose abnormalities due to drug transporter activity deficiency and drug transporter deficiency. In particular, the SLCO2B1 gene single nucleotide polymorphism of the present invention is a novel mutation gene discovered in Koreans and can contribute to the development of genetic diagnostic methods for Koreans by providing core base information in the development of a customized drug treatment method for Koreans. |
| priorityDate | 2015-04-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 454.